RBC Capital maintains Colgate-Palmolive at Outperform, raises price target to $105 from $104

What happened

RBC Capital kept its Outperform rating on Colgate-Palmolive and raised its price target to $105 from $104. The new target is 10.2% above the stock’s October 30 closing price of $95.29. Recent analyst targets listed in the article range from $95 to $105.

Confirmed

Global impact / market context

The higher target signals RBC sees more potential share-price gain, but it is an analyst estimate rather than a company forecast. If investors act on it, buying could support the shares; the small change alone does not establish any change in Colgate-Palmolive’s sales, costs, or cash available.

Analyst inference

The article lists three recent analyst targets, from $95 to $105, placing RBC’s $105 target at the top of that range. This shows views are not identical, while the target itself remains an estimate and does not guarantee the stock will reach that level.

Confirmed

What to watch

1. Compare future analyst updates with the listed $95–$105 range; a wider spread could indicate growing disagreement about Colgate-Palmolive’s expected share value. Analyst inference
2. Watch whether RBC changes its rating or target again, since a later revision could signal a changed view of the company’s prospects. Analyst inference
3. The article reports a 10.2% implied upside from the October 30 close, but gives no company results or business changes to explain the target increase. Confirmed

Evidence

• Original source link unavailable